Co-Diagnostics, Inc. (CODX) stock
CODXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$0.28−0.01 (-3.78%)
Close on Nov 11, 2026Market cap $1.74MP/E –Yield –
Co-Diagnostics total assets
Total assets on the balance sheet at the end of each period.
Co-Diagnostics's total assets was $12.79M at Sep 30, 2026. For fiscal 2025 it was $24.74M, down 61.1% from the year before. The highest annual figure on record is $160.03M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $24.74M | -61.1% |
| FY2024 | Dec 31, 2024 | $63.56M | -33.3% |
| FY2023 | Dec 31, 2023 | $95.32M | -22.6% |
| FY2022 | Dec 31, 2022 | $123.09M | -23.1% |
| FY2021 | Dec 31, 2021 | $160.03M | +124.6% |
| FY2020 | Dec 31, 2020 | $71.24M | +3115.7% |
| FY2019 | Dec 31, 2019 | $2.22M | +42.6% |
| FY2018 | Dec 31, 2018 | $1.55M | -66.7% |
| FY2017 | Dec 31, 2017 | $4.66M | +259.8% |
| FY2016 | Dec 31, 2016 | $1.30M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $12.79M | -71.4% |
| Q2 FY2026 | Jun 30, 2026 | $16.59M | -64.3% |
| Q1 FY2026 | Mar 31, 2026 | $21.50M | -61.0% |
| Q4 FY2025 | Dec 31, 2025 | $24.74M | -61.1% |
| Q3 FY2025 | Sep 30, 2025 | $44.74M | -38.2% |
| Q2 FY2025 | Jun 30, 2025 | $46.47M | -42.4% |
| Q1 FY2025 | Mar 31, 2025 | $55.15M | -36.4% |
| Q4 FY2024 | Dec 31, 2024 | $63.56M | -33.3% |
| Q3 FY2024 | Sep 30, 2024 | $72.38M | -33.4% |
| Q2 FY2024 | Jun 30, 2024 | $80.70M | -28.5% |
| Q1 FY2024 | Mar 31, 2024 | $86.67M | -25.9% |
| Q4 FY2023 | Dec 31, 2023 | $95.32M | -22.6% |
| Q3 FY2023 | Sep 30, 2023 | $108.68M | -26.5% |
| Q2 FY2023 | Jun 30, 2023 | $112.80M | -29.9% |
| Q1 FY2023 | Mar 31, 2023 | $117.00M | -31.6% |
| Q4 FY2022 | Dec 31, 2022 | $123.09M | -23.1% |
| Q3 FY2022 | Sep 30, 2022 | $147.84M | +40.3% |
| Q2 FY2022 | Jun 30, 2022 | $160.84M | +73.3% |
| Q1 FY2022 | Mar 31, 2022 | $171.15M | +111.0% |
| Q4 FY2021 | Dec 31, 2021 | $160.03M | +124.6% |
| Q3 FY2021 | Sep 30, 2021 | $105.36M | +92.8% |
| Q2 FY2021 | Jun 30, 2021 | $92.79M | +139.2% |
| Q1 FY2021 | Mar 31, 2021 | $81.12M | +296.1% |
| Q4 FY2020 | Dec 31, 2020 | $71.24M | +3115.7% |
| Q3 FY2020 | Sep 30, 2020 | $54.65M | +1333.7% |
| Q2 FY2020 | Jun 30, 2020 | $38.79M | +629.5% |
| Q1 FY2020 | Mar 31, 2020 | $20.48M | +234.6% |
| Q4 FY2019 | Dec 31, 2019 | $2.22M | +42.6% |
| Q3 FY2019 | Sep 30, 2019 | $3.81M | +40.5% |
| Q2 FY2019 | Jun 30, 2019 | $5.32M | +170.0% |
| Q1 FY2019 | Mar 31, 2019 | $6.12M | +84.0% |
| Q4 FY2018 | Dec 31, 2018 | $1.55M | -66.7% |
| Q3 FY2018 | Sep 30, 2018 | $2.71M | -55.2% |
| Q2 FY2018 | Jun 30, 2018 | $1.97M | +321.2% |
| Q1 FY2018 | Mar 31, 2018 | $3.33M | +156.8% |
| Q4 FY2017 | Dec 31, 2017 | $4.66M | – |
| Q3 FY2017 | Sep 30, 2017 | $6.05M | – |
| Q2 FY2017 | Jun 30, 2017 | $467.58K | – |
| Q4 FY2016 | Dec 31, 2016 | $1.30M | – |
See a number that looks wrong?